NCT04551963 2024-10-26Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell MalignanciesBeiGenePhase 1 Completed26 enrolled 20 charts
NCT05602597 2024-03-06HMPL-689 Drug Interaction Study With CYP3A Inhibitor/CYP2C9 Inhibitor/CYP3A Inducer/PPIHutchmedPhase 1 Completed59 enrolled
NCT03028103 2023-06-26Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor PatientsIpsenPhase 1 Completed32 enrolled 30 charts
NCT00075803 2023-01-04BMT CTN 0101Medical College of WisconsinPhase 3 Completed600 enrolled 22 charts
NCT00003883 2010-04-02Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow TransplantationFred Hutchinson Cancer CenterPhase 3 Completed578 enrolled